{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:55:01Z","timestamp":1781535301145,"version":"3.54.5"},"reference-count":196,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P01-HL059407"],"award-info":[{"award-number":["P01-HL059407"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["18POST34080184"],"award-info":[{"award-number":["18POST34080184"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jlr.2022.100169","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T22:33:40Z","timestamp":1642631620000},"page":"100169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4519-0798","authenticated-orcid":false,"given":"Cecilia","family":"Vitali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7397-6520","authenticated-orcid":false,"given":"Archna","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8549-9784","authenticated-orcid":false,"given":"Christina","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Schnall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3678-9421","authenticated-orcid":false,"given":"Kostas","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Rader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6808-3824","authenticated-orcid":false,"given":"Marina","family":"Cuchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2022.100169_bib1","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Lecithin cholesterol acyltransferase deficiency and fish eye disease","author":"Santamarina-Fojo","year":"2019"},{"key":"10.1016\/j.jlr.2022.100169_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1388-1981(00)00153-0","article-title":"Lecithin cholesterol acyltransferase","volume":"1529","author":"Jonas","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2022.100169_bib3","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/CIRCULATIONAHA.118.034706","article-title":"Complete and partial lecithin:cholesterol acyltransferase deficiency is differentially associated with atherosclerosis","volume":"138","author":"Oldoni","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2022.100169_bib4","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCULATIONAHA.108.848143","article-title":"Functional lecithin:cholesterol acyltransferase is not required for efficient atheroprotection in humans","volume":"120","author":"Calabresi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2022.100169_bib5","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jacc.2010.11.092","article-title":"Carriers of lecithin cholesterol acyltransferase gene mutations have accelerated atherogenesis as assessed by carotid 3.0-T magnetic resonance imaging [corrected]","volume":"58","author":"Duivenvoorden","year":"2011","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2022.100169_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.atherosclerosis.2012.09.022","article-title":"Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness","volume":"225","author":"van den Bogaard","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-2275(20)37433-2","article-title":"The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes","volume":"38","author":"Kuivenhoven","year":"1997","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100169_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150083","article-title":"Lipoprotein X causes renal disease in LCAT deficiency","volume":"11","author":"Ossoli","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2022.100169_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOL.0000000000000673","article-title":"Novel lecithin: cholesterol acyltransferase-based therapeutic approaches","volume":"31","author":"Freeman","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jlr.2022.100169_bib10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/ijms22020673","article-title":"Biomarkers in rare diseases","volume":"22","author":"Bax","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2022.100169_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.jlr.2022.100169_bib12","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/humu.21578","article-title":"High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations","volume":"32","author":"Holleboom","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jlr.2022.100169_bib13","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1194\/jlr.S120000720","article-title":"Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings","volume":"61","author":"Norum","year":"2020","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100169_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12944-019-1045-0","article-title":"Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia","volume":"18","author":"Tobar","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jlr.2022.100169_bib15","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3892\/ijmm.2014.1733","article-title":"Premature and severe cardiovascular disease in a Mexican male with markedly low high-density-lipoprotein-cholesterol levels and a mutation in the lecithin:cholesterol acyltransferase gene: a family study","volume":"33","author":"Posadas-S\u00e1nchez","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jlr.2022.100169_bib16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4103\/0971-4065.157802","article-title":"Co-existence of classic familial lecithin-cholesterol acyl transferase deficiency and fish eye disease in the same family","volume":"25","author":"Mahapatra","year":"2015","journal-title":"Indian J. Nephrol."},{"key":"10.1016\/j.jlr.2022.100169_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000045253","article-title":"Familial Lecithin:cholesterol acyltransferase deficiency with renal failure in two siblings. First case report from India","volume":"81","author":"Muthusethupathi","year":"1999","journal-title":"Nephron"},{"key":"10.1016\/j.jlr.2022.100169_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/0971-4065.179304","article-title":"Secret in the eyes - fish eye disease","volume":"26","author":"Ingle","year":"2016","journal-title":"Indian J. Nephrol."},{"key":"10.1016\/j.jlr.2022.100169_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12944-021-01498-6","article-title":"LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred","volume":"20","author":"Mehta","year":"2021","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jlr.2022.100169_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MNH.0000000000000463","article-title":"Sex hormones and their influence on chronic kidney disease","volume":"28","author":"Valdivielso","year":"2019","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.jlr.2022.100169_bib21","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/s41467-018-04193-w","article-title":"Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment","volume":"9","author":"Ashraf","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2022.100169_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2215\/CJN.04120417","article-title":"Whole exome sequencing of patients with steroid-resistant nephrotic syndrome","volume":"13","author":"Warejko","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jlr.2022.100169_bib23","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.kint.2018.10.031","article-title":"Monogenic causes of chronic kidney disease in adults","volume":"95","author":"Connaughton","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.jlr.2022.100169_bib24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/j.ajkd.2019.03.422","article-title":"The P274S mutation of lecithin-cholesterol acyltransferase (LCAT) and its clinical manifestations in a large kindred","volume":"74","author":"Fountoulakis","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jlr.2022.100169_bib25","first-page":"816","article-title":"Hereditary plasma lecithin-cholesterol acyl transferase deficiency: a heterozygous variant with erythrocyte membrane abnormalities","volume":"99","author":"Jain","year":"1982","journal-title":"J.\u00a0Lab. Clin. Med."},{"key":"10.1016\/j.jlr.2022.100169_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajh.2830160205","article-title":"Decreased sodium influx and abnormal red cell membrane lipids in a patient with familial plasma lecithin:cholesterol acyltransferase deficiency","volume":"16","author":"Murayama","year":"1984","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jlr.2022.100169_bib27","first-page":"147","article-title":"Alterations in erythrocyte membrane lipid and its fragility in a patient with familial lecithin:cholesterol acyltrasferase (LCAT) deficiency","volume":"49","author":"Suda","year":"2002","journal-title":"J.\u00a0Med. Invest."},{"key":"10.1016\/j.jlr.2022.100169_bib28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0005-2736(84)90328-6","article-title":"Self-adaptive modification of red-cell membrane lipids in lecithin:cholesterol acyltransferase deficiency. Lipid analysis and spin labeling","volume":"769","author":"Yawata","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2022.100169_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00365517809104922","article-title":"Familial lecithin:cholesterol acyltransferase deficiency. Further studies on plasma lipoproteins and plasma postheparin lipase activity of a patient with normal renal function","volume":"150","author":"Blomhoff","year":"1978","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"10.1016\/j.jlr.2022.100169_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2004.07.018","article-title":"Lecithin:cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up","volume":"177","author":"Ayyobi","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3109\/00365518709168946","article-title":"Impaired intermediate-density lipoprotein triglyceride hydrolysis in familial lecithin:cholesterol acyltransferase (LCAT) deficiency","volume":"47","author":"Murano","year":"1987","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.jlr.2022.100169_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/00365517809104921","article-title":"Lipid compositions of plasma major lipoproteins and lipoprotein lipase activity in hypolipidemic and hyperlipidemic siblings with familial LCAT deficiency","volume":"150","author":"Naito","year":"1978","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"10.1016\/j.jlr.2022.100169_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/00365517509108157","article-title":"Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: effects of dietary manipulation","volume":"142","author":"Glomset","year":"1975","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"10.1016\/j.jlr.2022.100169_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2013.02.034","article-title":"Amelioration of circulating lipoprotein profile and proteinuria in a patient with LCAT deficiency due to a novel mutation (Cys74Tyr) in the lid region of LCAT under a fat-restricted diet and ARB treatment","volume":"228","author":"Naito","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/00365517809104919","article-title":"Familial LCAT deficiency. Report of two patients from a Canadian family of Italian and Swedish descent","volume":"150","author":"Frohlich","year":"1978","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"10.1016\/j.jlr.2022.100169_bib36","first-page":"999","article-title":"Effects of long-term, low-fat diet on plasma apo E in familial LCAT deficiency","volume":"35","author":"Homma","year":"1993","journal-title":"Jpn. J. Nephrol."},{"key":"10.1016\/j.jlr.2022.100169_bib37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2169\/internalmedicine1962.28.765","article-title":"A\u00a0new case of familial lecithin:cholesterol acyltransferase (LCAT) deficiency\u2013paradoxical findings regarding LCAT mass and activity in 23 members of a family","volume":"28","author":"Takata","year":"1989","journal-title":"Jpn. J. Med."},{"key":"10.1016\/j.jlr.2022.100169_bib38","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/clinchem\/34.9.1805","article-title":"Cholesteryl ester transfer activity in plasma of patients with familial high-density lipoprotein deficiency","volume":"34","author":"Sparks","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jlr.2022.100169_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2008.08.038","article-title":"Functional LCAT is not required for macrophage cholesterol efflux to human serum","volume":"204","author":"Calabresi","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib40","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1194\/jlr.P072371","article-title":"Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency","volume":"58","author":"Gomaraschi","year":"2017","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100169_bib41","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/CIRCULATIONAHA.105.540427","article-title":"Compromised LCAT function is associated with increased atherosclerosis","volume":"112","author":"Hovingh","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2022.100169_bib42","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.bbalip.2011.08.006","article-title":"Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT","volume":"1821","author":"Tietjen","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2022.100169_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00365517409100640","article-title":"The ultrastructure of plasma lipoproteins in lecithin:cholesterol acyltransferase deficiency","volume":"137","author":"Forte","year":"1974","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"10.1016\/j.jlr.2022.100169_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0009-8981(74)90037-0","article-title":"Possible association between an abnormal low density lipoprotein and nephropathy in lecithin:cholesterol acyltransferase deficiency","volume":"54","author":"Gjone","year":"1974","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jlr.2022.100169_bib45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1124\/jpet.118.251876","article-title":"LCAT enzyme replacement therapy reduces LpX and improves kidney function in a mouse model of familial LCAT deficiency","volume":"368","author":"Vaisman","year":"2019","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jlr.2022.100169_bib46","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0002-9440(10)63386-X","article-title":"A\u00a0novel in\u00a0vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy","volume":"165","author":"Zhu","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jlr.2022.100169_bib47","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/ATVBAHA.114.303420","article-title":"Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency","volume":"34","author":"Kuroda","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2022.100169_bib48","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI106400","article-title":"Plasma lipoproteins in familial lecithin:cholesterol acyltransferase deficiency: lipid composition and reactivity in\u00a0vitro","volume":"49","author":"Glomset","year":"1970","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2022.100169_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9150(03)00241-7","article-title":"A\u00a0novel LCAT mutation (Phe382-->Val) in a kindred with familial LCAT deficiency and defective apolipoprotein B-100","volume":"170","author":"Nanjee","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib50","first-page":"411","article-title":"Renal failure in familial lecithin:cholesterol acyltransferase deficiency","volume":"51","author":"Borysiewicz","year":"1982","journal-title":"Q.\u00a0J. Med."},{"key":"10.1016\/j.jlr.2022.100169_bib51","first-page":"299","article-title":"Two novel mutations of lecithin:cholesterol acyltransferase (LCAT) gene and the influence of APOE genotypes on clinical manifestations","volume":"4","author":"Katayama","year":"2011","journal-title":"NDT Plus"},{"key":"10.1016\/j.jlr.2022.100169_bib52","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1194\/jlr.D090233","article-title":"Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex\u00a0vivo","volume":"60","author":"Freeman","year":"2019","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100169_bib53","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1161\/01.ATV.19.3.794","article-title":"Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli","volume":"19","author":"Jimi","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2022.100169_bib54","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1194\/jlr.P120000976","article-title":"Progression of chronic kidney disease in familial LCAT deficiency: a follow-up of the Italian cohort","volume":"61","author":"Pavanello","year":"2020","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100169_bib55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.atherosclerosis.2008.11.033","article-title":"Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy","volume":"205","author":"Yee","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5414\/CNP69213","article-title":"Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs)","volume":"69","author":"Aranda","year":"2008","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.jlr.2022.100169_bib57","first-page":"1665","article-title":"Renal transplantation in patients with familial lecithin:cholesterol-acetyltransferase deficiency","volume":"9","author":"Flatmark","year":"1977","journal-title":"Transplant. Proc"},{"key":"10.1016\/j.jlr.2022.100169_bib58","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000180835","article-title":"Renal failure in familial lecithin-cholesterol acyltransferase deficiency","volume":"18","author":"Myhre","year":"1977","journal-title":"Nephron"},{"key":"10.1016\/j.jlr.2022.100169_bib59","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2009.235","article-title":"The case: the eyes have it!","volume":"76","author":"Kettritz","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.jlr.2022.100169_bib60","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jacl.2015.12.007","article-title":"Familial lecithin:cholesterol acyltransferase deficiency: first-in-human treatment with enzyme replacement","volume":"10","author":"Shamburek","year":"2016","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.jlr.2022.100169_bib61","first-page":"25","article-title":"Familial lecithin-cholesterol acyltransferase (LCAT) deficiency; a differential of proteinuria","volume":"4","author":"Althaf","year":"2015","journal-title":"J.\u00a0Nephropathol."},{"key":"10.1016\/j.jlr.2022.100169_bib62","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10157-011-0409-1","article-title":"Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency","volume":"15","author":"Miarka","year":"2011","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.jlr.2022.100169_bib63","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1161\/01.ATV.0000175751.30616.13","article-title":"The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families","volume":"25","author":"Calabresi","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jlr.2022.100169_bib64","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICO.0000000000001804","article-title":"Ocular and Genetic Characteristics Observed in Two Cases of Fish-Eye Disease","volume":"38","author":"Ustaoglu","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.jlr.2022.100169_bib65","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF02602958","article-title":"A novel missense mutation (Asn5-->Ile) in lecithin: cholesterol acyltransferase (LCAT) gene in a Japanese patient with LCAT deficiency","volume":"26","author":"Okubo","year":"1996","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.jlr.2022.100169_bib66","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0006-291X(92)91772-I","article-title":"An amino acid exchange in exon I of the human lecithin: cholesterol acyltransferase (LCAT) gene is associated with fish eye disease","volume":"182","author":"Skretting","year":"1992","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.jlr.2022.100169_bib67","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0006-291X(91)92026-G","article-title":"Molecular defect in familial lecithin:cholesterol acyltransferase (LCAT) deficiency: a single nucleotide insertion in LCAT gene causes a complete deficient type of the disease","volume":"181","author":"Bujo","year":"1991","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.jlr.2022.100169_bib68","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.atherosclerosis.2009.05.014","article-title":"Characterization of a new LCAT mutation causing familial LCAT deficiency (FLD) and the role of APOE as a modifier gene of the FLD phenotype","volume":"207","author":"Baass","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib69","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cccn.2004.01.014","article-title":"T13M mutation of lecithin-cholesterol acyltransferase gene causes fish-eye disease","volume":"343","author":"Miida","year":"2004","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"10.1016\/j.jlr.2022.100169_bib70","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.kint.2016.07.005","article-title":"The Case | Nephrotic syndrome with corneal opacities","volume":"91","author":"Ozkok","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.jlr.2022.100169_bib71","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0022-2275(20)37266-7","article-title":"Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency","volume":"38","author":"Yang","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2022.100169_bib72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1098-1004(1996)8:1<79::AID-HUMU13>3.0.CO;2-O","article-title":"Complete deficiency of plasma lecithin-cholesterol acyltransferase (LCAT) activity due to a novel homozygous mutation (Gly-30-Ser) in the LCAT gene","volume":"8","author":"Owen","year":"1996","journal-title":"Human mutation"},{"key":"10.1016\/j.jlr.2022.100169_bib73","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/ndt\/gfm311","article-title":"Molecular characterization of two patients with severe LCAT deficiency","volume":"22","author":"Charlton-Menys","year":"2007","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"10.1016\/j.jlr.2022.100169_bib74","article-title":"Finding a very rare mutation in non-Caucasian LCAT patients from Southwest Asia for the first time","author":"Oliaei","year":"2018","journal-title":"Journal of cellular biochemistry"},{"key":"10.1016\/j.jlr.2022.100169_bib75","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1172\/JCI116248","article-title":"Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease","volume":"91","author":"Funke","year":"1993","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.jlr.2022.100169_bib76","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00041433-199104000-00009","article-title":"Lecithin: cholesterol acyltransferase deficiency and fish-eye disease","volume":"2","author":"Assmann","year":"1991","journal-title":"Current opinion in lipidology"},{"key":"10.1016\/j.jlr.2022.100169_bib77","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacl.2017.08.008","article-title":"A novel homozygous mutation causing lecithin-cholesterol acyltransferase deficiency in a proband of Romanian origin with a record of extreme gestational hyperlipidemia","volume":"11","author":"Rial-Crestelo","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jlr.2022.100169_bib78","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/01.ATV.17.7.1382","article-title":"Molecular basis of fish-eye disease in a patient from Spain. Characterization of a novel mutation in the LCAT gene and lipid analysis of the cornea","volume":"17","author":"Blanco-Vaca","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jlr.2022.100169_bib79","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-224129","article-title":"LCAT deficiency as a cause of proteinuria and corneal opacification","author":"Morales","year":"2018","journal-title":"BMJ case reports 2018"},{"key":"10.1016\/j.jlr.2022.100169_bib80","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2796.1992.tb00953.x","article-title":"Familial high-density-lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descent","volume":"231","author":"Kastelein","year":"1992","journal-title":"Journal of internal medicine"},{"key":"10.1016\/j.jlr.2022.100169_bib81","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1073\/pnas.88.11.4855","article-title":"A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity","volume":"88","author":"Funke","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jlr.2022.100169_bib82","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1172\/JCI118348","article-title":"A unique genetic and biochemical presentation of fish-eye disease","volume":"96","author":"Kuivenhoven","year":"1995","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.jlr.2022.100169_bib83","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0021-9150(99)00112-4","article-title":"Classical LCAT deficiency resulting from a novel homozygous dinucleotide deletion in exon 4 of the human lecithin: cholesterol acyltransferase gene causing a frameshift and stop codon at residue 144","volume":"146","author":"Teh","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib84","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.5551\/jat.5488","article-title":"Point mutation (C to T) of the LCAT gene resulting in A140C substitution","volume":"17","author":"Hirashio","year":"2010","journal-title":"Journal of atherosclerosis and thrombosis"},{"key":"10.1016\/j.jlr.2022.100169_bib85","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00214196","article-title":"A single G to A nucleotide transition in exon IV of the lecithin: cholesterol acyltransferase (LCAT) gene results in an Arg140 to His substitution and causes LCAT-deficiency","volume":"96","author":"Steyrer","year":"1995","journal-title":"Hum Genet"},{"key":"10.1016\/j.jlr.2022.100169_bib86","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/0140-6736(91)90665-C","article-title":"Differential phenotypic expression by three mutant alleles in familial lecithin:cholesterol acyltransferase deficiency","volume":"338","author":"Gotoda","year":"1991","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jlr.2022.100169_bib87","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11739-011-0712-6","article-title":"A woman with low HDL cholesterol and corneal opacity","volume":"7","author":"Lucchi","year":"2012","journal-title":"Internal and emergency medicine"},{"key":"10.1016\/j.jlr.2022.100169_bib88","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00193195","article-title":"Lecithin cholesterol acyl transferase deficiency: molecular analysis of a mutated allele","volume":"85","author":"Taramelli","year":"1990","journal-title":"Hum Genet"},{"key":"10.1016\/j.jlr.2022.100169_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8111860","article-title":"Lipid Profile Rather Than the LCAT Mutation Explains Renal Disease in Familial LCAT Deficiency","volume":"8","author":"Lamiquiz-Moneo","year":"2019","journal-title":"Journal of clinical medicine"},{"key":"10.1016\/j.jlr.2022.100169_bib90","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0026-0495(97)90180-3","article-title":"Fish-eye disease: structural and in vivo metabolic abnormalities of high-density lipoproteins","volume":"46","author":"Elkhalil","year":"1997","journal-title":"Metabolism: clinical and experimental"},{"key":"10.1016\/j.jlr.2022.100169_bib91","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1515\/CCLM.2007.102","article-title":"A novel frameshift mutation of the lecithin:cholesterol acyltransferase (LCAT) gene associated with renal failure in familial LCAT deficiency","volume":"45","author":"Bender","year":"2007","journal-title":"Clinical chemistry and laboratory medicine"},{"key":"10.1016\/j.jlr.2022.100169_bib92","doi-asserted-by":"crossref","first-page":"713","DOI":"10.5551\/jat.8003","article-title":"Molecular analysis of a novel LCAT mutation (Gly179--> Arg) found in a patient with complete LCAT deficiency","volume":"18","author":"Wang","year":"2011","journal-title":"Journal of atherosclerosis and thrombosis"},{"key":"10.1016\/j.jlr.2022.100169_bib93","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1210\/jc.2011-1846","article-title":"LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals","volume":"97","author":"Haase","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jlr.2022.100169_bib94","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0021-9150(94)90056-6","article-title":"Identification of the homozygous missense mutation in the lecithin:cholesterol-acyltransferase (LCAT) gene, causing LCAT familial deficiency in two French patients","volume":"105","author":"Dorval","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib95","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/01.ATV.18.4.591","article-title":"Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels","volume":"18","author":"Miettinen","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jlr.2022.100169_bib96","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/8904_2017_57","article-title":"Novel Missense LCAT Gene Mutation Associated with an Atypical Phenotype of Familial LCAT Deficiency in Two Portuguese Brothers","volume":"40","author":"Castro-Ferreira","year":"2018","journal-title":"JIMD reports"},{"key":"10.1016\/j.jlr.2022.100169_bib97","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0014-5793(92)80795-I","article-title":"The genetic defect of the original Norwegian lecithin:cholesterol acyltransferase deficiency families","volume":"309","author":"Skretting","year":"1992","journal-title":"FEBS letters"},{"key":"10.1016\/j.jlr.2022.100169_bib98","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0022-2275(20)39714-5","article-title":"Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344-->Ser","volume":"36","author":"Moriyama","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2022.100169_bib99","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1194\/jlr.M088203","article-title":"Genetic and secondary causes of severe HDL deficiency and cardiovascular disease","volume":"59","author":"Geller","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2022.100169_bib100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacl.2011.07.002","article-title":"Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature","volume":"5","author":"Roshan","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jlr.2022.100169_bib101","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0006-291X(91)90129-U","article-title":"Lecithin-cholesterol acyltransferase (LCAT) deficiency with a missense mutation in exon 6 of the LCAT gene","volume":"178","author":"Maeda","year":"1991","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.jlr.2022.100169_bib102","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1172\/JCI116962","article-title":"Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease","volume":"93","author":"Rader","year":"1994","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.jlr.2022.100169_bib103","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1172\/JCI116591","article-title":"Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis","volume":"92","author":"Klein","year":"1993","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.jlr.2022.100169_bib104","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.atherosclerosis.2005.06.022","article-title":"Familial lecithin-cholesterol acyltransferase deficiency: biochemical characteristics and molecular analysis of a new LCAT mutation in a Polish family","volume":"185","author":"Idzior-Walus","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2011.01.025","article-title":"Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase","volume":"216","author":"Holleboom","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib106","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s10384-003-0007-1","article-title":"Corneal and macular manifestations in a case of deficient lecithin: cholesterol acyltransferase","volume":"48","author":"Hirano","year":"2004","journal-title":"Japanese journal of ophthalmology"},{"key":"10.1016\/j.jlr.2022.100169_bib107","first-page":"29","article-title":"Familial LCAT deficiency: from renal replacement to enzyme replacement","volume":"71","author":"Stoekenbroek","year":"2013","journal-title":"The Netherlands journal of medicine"},{"key":"10.1016\/j.jlr.2022.100169_bib108","first-page":"375","article-title":"LCAT deficiency: molecular and phenotypic characterization of an Italian family","volume":"19","author":"Gigante","year":"2006","journal-title":"J Nephrol"},{"key":"10.1016\/j.jlr.2022.100169_bib109","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS Recommendations for the Description of Sequence Variants: 2016 Update","volume":"37","author":"den Dunnen","year":"2016","journal-title":"Human mutation"},{"key":"10.1016\/j.jlr.2022.100169_bib110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/hmg\/4.1.143","article-title":"Deficiency of lecithin:cholesterol acyltransferase due to compound heterozygosity of two novel mutations (Gly33Arg and 30 bp ins) in the LCAT gene","volume":"4","author":"Wiebusch","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jlr.2022.100169_bib111","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/01.ATV.15.4.460","article-title":"Two different allelic mutations in a Finnish family with lecithin:cholesterol acyltransferase deficiency","volume":"15","author":"Miettinen","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jlr.2022.100169_bib112","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0021-9150(92)90172-D","article-title":"Non-cholesterol sterols, absorption and synthesis of cholesterol and apolipoprotein A-I kinetics in a Finnish lecithin-cholesterol acyltransferase deficient family","volume":"95","author":"Gylling","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib113","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.ATV.16.2.294","article-title":"Two novel molecular defects in the LCAT gene are associated with fish eye disease","volume":"16","author":"Kuivenhoven","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jlr.2022.100169_bib114","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/ndt\/gfh179","article-title":"A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene","volume":"19","author":"Frasca","year":"2004","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"10.1016\/j.jlr.2022.100169_bib115","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/ndt\/gfm233","article-title":"Stability of lipids on peritoneal dialysis in a patient with familial LCAT deficiency","volume":"22","author":"Weber","year":"2007","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"10.1016\/j.jlr.2022.100169_bib116","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2005.08.038","article-title":"Compound heterozygosity (G71R\/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease","volume":"187","author":"Horl","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib117","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1515\/CCLM.1998.074","article-title":"Molecular diagnosis of lecithin: cholesterol acyltransferase deficiency in a presymptomatic proband","volume":"36","author":"Cirera","year":"1998","journal-title":"Clinical chemistry and laboratory medicine"},{"key":"10.1016\/j.jlr.2022.100169_bib118","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-2275(20)37633-1","article-title":"A new molecular defect in the lecithin: cholesterol acyltransferase (LCAT) gene associated with fish eye disease","volume":"37","author":"Contacos","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2022.100169_bib119","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1172\/JCI118800","article-title":"An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease)","volume":"98","author":"Kuivenhoven","year":"1996","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.jlr.2022.100169_bib120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-2275(20)41318-5","article-title":"Two different allelic mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in classic LCAT deficiency: LCAT (tyr83-->stop) and LCAT (tyr156-->asn)","volume":"34","author":"Klein","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2022.100169_bib121","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0022-2275(20)39851-5","article-title":"Lecithin: cholesterol acyltransferase deficiency: identification of two defective alleles in fibroblast cDNA","volume":"36","author":"Miller","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2022.100169_bib122","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/ctr.12826","article-title":"Sequential kidney-liver transplantation from the same living donor for lecithin cholesterol acyl transferase deficiency","volume":"30","author":"Ahmad","year":"2016","journal-title":"Clinical transplantation"},{"key":"10.1016\/j.jlr.2022.100169_bib123","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0021-9150(97)06079-6","article-title":"Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147--> Trp) and LCAT (Tyr171--> Stop)","volume":"131","author":"Guerin","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib124","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.atherosclerosis.2009.03.001","article-title":"Two novel frame shift mutations in lecithin:cholesterol acyltransferase (LCAT) gene associated with a familial LCAT deficiency phenotype","volume":"206","author":"Park","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/01913123.2010.551578","article-title":"Lecithin: Cholesterol Acyltransferase (LCAT) Deficiency: renal lesions with early graft recurrence","volume":"35","author":"Strom","year":"2011","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.jlr.2022.100169_bib126","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000046001","article-title":"Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutations","volume":"88","author":"Sessa","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.jlr.2022.100169_bib127","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/S0022-2275(20)32175-1","article-title":"Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: structure-function relationships and studies in a compound heterozygous proband","volume":"39","author":"Argyropoulos","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2022.100169_bib128","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI115612","article-title":"Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123\u2013--Ile) and lecithin-cholesterol acyltransferase (Thr347\u2013--Met)","volume":"89","author":"Klein","year":"1992","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.jlr.2022.100169_bib129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0021-9150(00)00640-7","article-title":"A novel TC deletion resulting in Pro(260)-->Stop in the human LCAT gene is associated with a dominant effect on HDL-cholesterol","volume":"156","author":"Kasid","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jacl.2012.01.006","article-title":"Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia","volume":"6","author":"Conca","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jlr.2022.100169_bib131","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5414\/CN106484","article-title":"Lecithin-cholesterol acyltransferase (LCAT) deficiency without mutations in the coding sequence: a case report and literature review","volume":"76","author":"Shoji","year":"2011","journal-title":"Clinical nephrology"},{"key":"10.1016\/j.jlr.2022.100169_bib132","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jcp.52.3.228","article-title":"A first British case of fish-eye disease presenting at age 75 years: a double heterozygote for defined and new mutations affecting LCAT structure and expression","volume":"52","author":"Winder","year":"1999","journal-title":"Journal of clinical pathology"},{"key":"10.1016\/j.jlr.2022.100169_bib133","first-page":"23","article-title":"An unusual presentation of LCAT deficiency as nephrotic syndrome with normal serum HDL-C level","volume":"6","author":"Balwani","year":"2017","journal-title":"Journal of nephropharmacology"},{"key":"10.1016\/j.jlr.2022.100169_bib134","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2005.01.048","article-title":"Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes","volume":"182","author":"Pisciotta","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib135","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/ndt\/gfm760","article-title":"Dramatic atherosclerotic vascular burden in a patient with familial lecithin-cholesterol acyltransferase (LCAT) deficiency","volume":"23","author":"Scarpioni","year":"2008","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"10.1016\/j.jlr.2022.100169_bib136","first-page":"167","article-title":"Familial lecithin:cholesterol acyltransferase deficiency - a new metabolic disease with renal involvement","volume":"10","author":"Gjone","year":"1981","journal-title":"Advances in nephrology from the Necker Hospital"},{"key":"10.1016\/j.jlr.2022.100169_bib137","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00007890-199307000-00048","article-title":"Long-term follow-up of a patient with lecithin cholesterol acyltransferase deficiency syndrome after kidney transplantation","volume":"56","author":"Horina","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.jlr.2022.100169_bib138","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/00365517409100636","article-title":"Familial lecithin:cholesterol acyltransferase deficiency. Studies on lipid composition and morphology of tissues","volume":"137","author":"Stokke","year":"1974","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1016\/j.jlr.2022.100169_bib139","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/nep.12554","article-title":"Recurrent glomerulopathy in a renal allograft due to lecithin cholesterol acyltransferase deficiency","volume":"21","author":"Liew","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jlr.2022.100169_bib140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1432-2277.1992.tb01741.x","article-title":"Successful renal transplantation in a patient with familial lecithin:cholesterol acyltransferase deficiency","volume":"5","author":"Stoynovska","year":"1992","journal-title":"Transpl Int"},{"key":"10.1016\/j.jlr.2022.100169_bib141","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1093\/ndt\/12.11.2430","article-title":"Recurrence of lecithin cholesterol acyltransferase deficiency after kidney transplantation","volume":"12","author":"Panescu","year":"1997","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"10.1016\/j.jlr.2022.100169_bib142","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5414\/CN107007","article-title":"A case of familial lecithin-cholesterol acyltransferase deficiency on hemodialysis for over 20 years","volume":"76","author":"Tsuchiya","year":"2011","journal-title":"Clinical nephrology"},{"key":"10.1016\/j.jlr.2022.100169_bib143","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.0954-6820.1978.tb08427.x","article-title":"Familial lecithin: cholesterol acyltransferase deficiency complicated with unconjugated hyperbilirubinemia and peripheral neuropathy. The first reported cases in the Far East","volume":"204","author":"Iwamoto","year":"1978","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jlr.2022.100169_bib144","first-page":"331","article-title":"Lecithin cholesterol acyltransferase deficiency: ultrastructural examination of sequential renal biopsies","volume":"4","author":"Lager","year":"1991","journal-title":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc"},{"key":"10.1016\/j.jlr.2022.100169_bib145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000046287","article-title":"Marked atherosclerosis in a patient with familiar lecithin: cholesterol acyltransferase deficiency associated with end-stage renal disease and diabetes mellitus","volume":"21","author":"Homma","year":"2001","journal-title":"American journal of nephrology"},{"key":"10.1016\/j.jlr.2022.100169_bib146","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0272-6386(86)80055-5","article-title":"Nephropathy of familial lecithin-cholesterol acyltransferase deficiency: report of a case","volume":"7","author":"Ohta","year":"1986","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"key":"10.1016\/j.jlr.2022.100169_bib147","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/0971-4065.158575","article-title":"An unusual case of nephrotic syndrome","volume":"26","author":"Sahay","year":"2016","journal-title":"Indian journal of nephrology"},{"key":"10.1016\/j.jlr.2022.100169_bib148","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000167056","article-title":"Renal lesions in familial lecithin-cholesterol acyltransferase deficiency. Ultrastructural heterogeneity of glomerular changes","volume":"6","author":"Imbasciati","year":"1986","journal-title":"American journal of nephrology"},{"key":"10.1016\/j.jlr.2022.100169_bib149","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0046-8177(82)80187-1","article-title":"Unusual renal biopsy findings in a patient with familial lecithin:cholesterol acyltransferase deficiency","volume":"13","author":"Magil","year":"1982","journal-title":"Human pathology"},{"key":"10.1016\/j.jlr.2022.100169_bib150","first-page":"65","article-title":"Detection of heterozygotes for familial lecithin: cholesterol acyltransferase (LCAT) deficiency","volume":"34","author":"Frohlich","year":"1982","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jlr.2022.100169_bib151","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.metabol.2009.04.033","article-title":"Splenomegaly with sea-blue histiocytosis, dyslipidemia, and nephropathy in a patient with lecithin-cholesterol acyltransferase deficiency: a clinicopathologic correlation","volume":"58","author":"Naghashpour","year":"2009","journal-title":"Metabolism: clinical and experimental"},{"key":"10.1016\/j.jlr.2022.100169_bib152","first-page":"179","article-title":"Familial lecithin-cholesterol acyltransferase deficiency","volume":"12","author":"Jahanzad","year":"2009","journal-title":"Archives of Iranian medicine"},{"key":"10.1016\/j.jlr.2022.100169_bib153","first-page":"333","article-title":"Lecithin-cholesterol acyltransferase deficiency: first report of case in a United States citizen","volume":"94","author":"Neumann","year":"1994","journal-title":"The Journal of the American Osteopathic Association"},{"key":"10.1016\/j.jlr.2022.100169_bib154","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0021-9150(93)90191-V","article-title":"Familial lecithin:cholesterol acyltransferase deficiency: further resolution of lipoprotein particle heterogeneity in the low density interval","volume":"104","author":"Guerin","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2022.100169_bib155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.0954-6820.1968.tb10449.x","article-title":"Familial serum cholesterol ester deficiency. Clinical study of a patient with a new syndrome","volume":"183","author":"Gjone","year":"1968","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jlr.2022.100169_bib156","first-page":"73","article-title":"Familial lecithin:cholesterol acyltransferase deficiency\u2013a clinical survey","volume":"137","author":"Gjone","year":"1974","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1016\/j.jlr.2022.100169_bib157","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.0954-6820.1981.tb09767.x","article-title":"Familial lecithin:cholesterol acyltransferase deficiency. Report of a fourth family from northwestern Norway","volume":"210","author":"Gjone","year":"1981","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jlr.2022.100169_bib158","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1699-0463.1973.tb03561.x","article-title":"Familial plasma lecithin: cholesterol acyltransferase (LCAT) deficiency. Ultrastructural aspects of a new syndrome with particular reference to lesions in the kidneys and the spleen","volume":"81","author":"Hovig","year":"1973","journal-title":"Acta pathologica et microbiologica Scandinavica. Section A, Pathology"},{"key":"10.1016\/j.jlr.2022.100169_bib159","first-page":"211","article-title":"Familial LCAT deficiency in a child with nephrotic syndrome","volume":"82","author":"Rajpal","year":"2014","journal-title":"Clinical nephrology"},{"key":"10.1016\/j.jlr.2022.100169_bib160","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/ajcp\/88.4.510","article-title":"Hereditary lecithin-cholesterol acyltransferase deficiency. Case report of a German patient","volume":"88","author":"Weber","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jlr.2022.100169_bib161","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.ajkd.2015.07.040","article-title":"Histiocytic and Nonhistiocytic Glomerular Lesions: Foam Cells and Their Mimickers","volume":"67","author":"Kaur","year":"2016","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"key":"10.1016\/j.jlr.2022.100169_bib162","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000181224","article-title":"Hereditary lecithin cholesterol acyltransferase deficiency. Report of a new family with two afflicted sisters","volume":"20","author":"Chevet","year":"1978","journal-title":"Nephron"},{"key":"10.1016\/j.jlr.2022.100169_bib163","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.270.16.9443","article-title":"In vitro expression of structural defects in the lecithin-cholesterol acyltransferase gene","volume":"270","author":"Klein","year":"1995","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.jlr.2022.100169_bib164","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0022-2275(20)39854-0","article-title":"In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase","volume":"36","author":"Qu","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2022.100169_bib165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2362.1982.tb00938.x","article-title":"Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia","volume":"12","author":"Carlson","year":"1982","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jlr.2022.100169_bib166","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.0954-6820.1985.tb03252.x","article-title":"Paradoxical esterification of plasma cholesterol in fish eye disease","volume":"217","author":"Carlson","year":"1985","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jlr.2022.100169_bib167","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.ATV.14.7.1137","article-title":"Characterization of subspecies of apolipoprotein A-I-containing lipoprotein in homozygotes for familial lecithin:cholesterol acyltransferase deficiency","volume":"14","author":"Ohta","year":"1994","journal-title":"Arteriosclerosis and thrombosis : a journal of vascular biology"},{"key":"10.1016\/j.jlr.2022.100169_bib168","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-2275(20)33339-3","article-title":"Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity","volume":"40","author":"Peelman","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2022.100169_bib169","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0925-4439(93)90039-4","article-title":"Lecithin:cholesterol acyltransferase deficiency: identification of a causative gene mutation and a co-inherited protein polymorphism","volume":"1181","author":"Hill","year":"1993","journal-title":"Biochimica et biophysica acta"},{"key":"10.1016\/j.jlr.2022.100169_bib170","doi-asserted-by":"crossref","first-page":"32561","DOI":"10.1074\/jbc.273.49.32561","article-title":"Structural and functional properties of two mutants of lecithin-cholesterol acyltransferase (T123I and N228K)","volume":"273","author":"Adimoolam","year":"1998","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.jlr.2022.100169_bib171","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1021\/acs.biochem.5b00180","article-title":"The Effect of Natural LCAT Mutations on the Biogenesis of HDL","volume":"54","author":"Fotakis","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.jlr.2022.100169_bib172","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0022-2275(20)32384-1","article-title":"Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease","volume":"41","author":"Vanloo","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2022.100169_bib173","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-2275(20)41321-5","article-title":"Recombinant lecithin:cholesterol acyltransferase containing a Thr123-->Ile mutation esterifies cholesterol in low density lipoprotein but not in high density lipoprotein","volume":"34","author":"O","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jlr.2022.100169_bib174","doi-asserted-by":"crossref","first-page":"20313","DOI":"10.1074\/jbc.M117.802736","article-title":"A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I","volume":"292","author":"Manthei","year":"2017","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.jlr.2022.100169_bib175","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1172\/JCI117598","article-title":"The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma","volume":"94","author":"Steyrer","year":"1994","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.jlr.2022.100169_bib176","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.0954-6820.1983.tb08591.x","article-title":"A new case of familial LCAT deficiency","volume":"214","author":"Vergani","year":"1983","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jlr.2022.100169_bib177","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0005-2760(85)90280-2","article-title":"Defective enzyme causes lecithin-cholesterol acyltransferase deficiency in a Japanese kindred","volume":"835","author":"Albers","year":"1985","journal-title":"Biochimica et biophysica acta"},{"key":"10.1016\/j.jlr.2022.100169_bib178","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2362.1984.tb02100.x","article-title":"Effects of plasma infusion on plasma lipids, apoproteins and plasma enzyme activities in familial lecithin: cholesterol acyltransferase deficiency","volume":"14","author":"Murayama","year":"1984","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jlr.2022.100169_bib179","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0954-6820.1981.tb09849.x","article-title":"Familial lecithin-cholesterol acyltransferase deficiency in four Norwegian Families. Evidence for low levels of a functionally defective enzyme","volume":"210","author":"Albers","year":"1981","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jlr.2022.100169_bib180","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.0954-6820.1982.tb03204.x","article-title":"Familial plasma lecithin: cholesterol acyltransferase deficiency. A new family with partial LCAT activity","volume":"212","author":"Sakuma","year":"1982","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jlr.2022.100169_bib181","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF00295608","article-title":"Familial lecithin-cholesterol acyltransferase deficiency in a Japanese family: evidence for functionally defective enzyme in homozygotes and obligate heterozygotes","volume":"62","author":"Albers","year":"1982","journal-title":"Hum Genet"},{"key":"10.1016\/j.jlr.2022.100169_bib182","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2362.1991.tb01418.x","article-title":"A 'Fish-eye disease' familial condition with massive corneal opacities and hypoalphalipoproteinaemia: clinical, biochemical and genetic features","volume":"21","author":"Clerc","year":"1991","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jlr.2022.100169_bib183","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1399-0004.1981.tb02063.x","article-title":"Lecithin-cholesterol-acyltransferase deficiency: autosomal recessive transmission in a large kindred","volume":"19","author":"Utermann","year":"1981","journal-title":"Clinical genetics"},{"key":"10.1016\/j.jlr.2022.100169_bib184","first-page":"702","article-title":"Genetic control of lecithin-cholesterol acyltransferase (LCAT): measurement of LCAT mass in a large kindred with LCAT deficiency","volume":"33","author":"Albers","year":"1981","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jlr.2022.100169_bib185","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2169\/internalmedicine.33.677","article-title":"Japanese family with a deficiency of lecithin:cholesterol acyltransferase (LCAT)","volume":"33","author":"Naito","year":"1994","journal-title":"Internal medicine (Tokyo, Japan)"},{"key":"10.1016\/j.jlr.2022.100169_bib186","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jacl.2013.11.005","article-title":"A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy","volume":"8","author":"Dimick","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jlr.2022.100169_bib187","first-page":"357","article-title":"Very low levels of HDL cholesterol and atherosclerosis, a variable relationship\u2013a review of LCAT deficiency","volume":"8","author":"Savel","year":"2012","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jlr.2022.100169_bib188","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jacl.2018.06.006","article-title":"Paradoxical fall in proteinuria during pregnancy in an LCAT-deficient patient-A case report","volume":"12","author":"Hanna","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jlr.2022.100169_bib189","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0005-2760(97)00198-7","article-title":"T-->G or T-->A mutation introduced in the branchpoint consensus sequence of intron 4 of lecithin:cholesterol acyltransferase (LCAT) gene: intron retention causing LCAT deficiency","volume":"1391","author":"Li","year":"1998","journal-title":"Biochimica et biophysica acta"},{"key":"10.1016\/j.jlr.2022.100169_bib190","doi-asserted-by":"crossref","first-page":"18079","DOI":"10.1074\/jbc.M910197199","article-title":"Characterization of the effects of mutations in the putative branchpoint sequence of intron 4 on the splicing within the human lecithin:cholesterol acyltransferase gene","volume":"275","author":"Li","year":"2000","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.jlr.2022.100169_bib191","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0026-0495(88)90021-2","article-title":"Plasma lipoprotein abnormalities in heterozygotes for familial lecithin:cholesterol acyltransferase deficiency","volume":"37","author":"Frohlich","year":"1988","journal-title":"Metabolism: clinical and experimental"},{"key":"10.1016\/j.jlr.2022.100169_bib192","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.0954-6820.1987.tb00896.x","article-title":"Hypoalphalipoproteinemia resembling fish eye disease","volume":"221","author":"Frohlich","year":"1987","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jlr.2022.100169_bib193","unstructured":"National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. In."},{"key":"10.1016\/j.jlr.2022.100169_bib194","unstructured":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). In."},{"key":"10.1016\/j.jlr.2022.100169_bib195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C.","volume":"367","author":"Inker","year":"2012","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.jlr.2022.100169_bib196","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227522000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227522000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T18:30:39Z","timestamp":1758306639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227522000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":196,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0022227522000025"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2022.100169","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2022.100169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100169"}}